L’Occitane announces FY2018 interim results

By Lucy Whitehouse

- Last updated on GMT

Related tags Generally accepted accounting principles Brand management

L’Occitane announces FY2018 interim results
The global, natural ingredient-based cosmetics company has announced its results for the period ending September 2017, revealing that progress is being made particularly with its online offering.

Despite a challenging retail backdrop, encouraging progress was made in key emerging markets, emerging brands and online channels, the company says.

It saw its net sales grow 2.3% at constant rates (like-for-like), and its online sales are up 22.6%, which the company puts down to successful marketing investments.

The Group describes its balance sheet as remaining healthy during the period, with its net cash position amounting to €167.2 million as at 30 September 2017.

Moving forward, Reinold Geiger, Chairman and Chief Executive Officer of L’Occitane, said: “We will continue to push forward our omni-channel sales strategy, as well as our digital marketing and brand building efforts in order to boost our sales performance as we head into the historically more active second half of the year​.”

Top 8 highlights from L’Occitane’s results

1. Despite a challenging retail backdrop, encouraging progress was made in key emerging markets, emerging brands and online channels.

2. Net sales were €548.2 million, an improvement of 1.1% at constant rates (up 2.3% on a like-for-like basis).

3. Gross profit margin expanded by 0.6 points to 82.8%.

4. China and Brazil were the fastest-growing countries, with sales growth at constant rates of 22.7% and 13.2% respectively. Meanwhile, sales growth in Hong Kong further stabilised.

5. Web sell-out sales (e.g. T-mall) grew 22.6%, equivalent to 12.9% of total sell-out sales.

6. Emerging brands (Melvita, L’Occitane au Brésil, Erborian) delivered double-digit growth.

7. Continued investment in E-commerce, digital marketing, brand positioning and R&D boosted brand awareness.

8. Net profit fell to €10.7 million due to unfavourable foreign exchange rates, one-off effects and strong seasonality.

Related news

Show more

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast